UK's MHRA: Novo’s Semaglutide Injection Approved To Treat Metabolic-Associated Steatohepatitis In Adults With Moderate-to-Advanced Liver Fib
UK's MHRA: Novo’s Semaglutide Injection Approved To Treat Metabolic-Associated Steatohepatitis In Adults With Moderate-to-Advanced Liver Fibrosis
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.